A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...
This interesting study presents valuable information on how human cytomegalovirus (HCMV) infection disrupts the activity of the TEAD1 transcription factor, leading to widespread chromatin alterations.
In order to one day eliminate cervical cancer, the World Health Organization has set out a global strategy: 90 percent of girls to be vaccinated by the age of 15; 70 percent of women screened by the ...